| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| Avinger (AVGR) | Canaccord Genuity/ Cowen | $69.00 | n.a. | |||
| BiondVax Pharmaceuticals Ltd. (BVXV) | Aegis Capital Corp | $10.60 | n.a. | |||
| Carbylan Therapeutics (CBYL) | Leerink Partners | $86.25 | n.a. | |||
| Flex Pharma (FLKS) | Jefferies/ Piper Jaffray | $60.00 | n.a. | |||
| HTG Molecular Diagnostics (HTGM) | Leerink Partners | $60.00 | n.a. | |||
| Inovalon Holdings (INOV) | Goldman Sachs/ Morgan Stanley/ Citigroup/ BofA Merrill Lynch/ UBS Investment Bank | $500.00 | n.a. | |||
| Nexvet Biopharma plc (NVET) | BofA Merrill Lynch/ Cowen and Company | $60.00 | n.a. | |||
| Shake Shack (SHAK) | J.P. Morgan/ Morgan Stanley | $100.00 | n.a. | |||
| Spark Therapeutics (ONCE) | J.P. Morgan/ Credit Suisse | $86.25 | n.a. | |||
| Tracon Pharmaceuticals (TCON) | Wells Fargo Securities/ Stifel | $57.50 | n.a. | |||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Columbia Pipeline Partners LP (CPPL) | Barclays/ Citigroup/ BofA Merrill Lynch/ Goldman Sachs/ J.P. Morgan/ Morgan Stanley/ Wells Fargo Securities | $800.00 | n.a. | |||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Dec. 29, 2014 | Manager(s) | Offered | Raised | Price | 1/2/15 | Change |
| None | ||||||
